Medical Faculty, Norwegian University of Science And Technology
Trondheim, 7441, Norway
Location status: Recruiting
Location contact
Gunnar Morken, MD PhD
CONTACT
Gunnar Morken, MD PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT00201526
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.
Interested in participating?
Request InfoAll sexes
Observational
Trondheim, 7441, Norway
Location status: Recruiting
Gunnar Morken, MD PhD
CONTACT
Gunnar Morken, MD PhD
PRINCIPAL_INVESTIGATOR
Norway is both social, genetically and culturally a homogeneous society. The health service is public and has a nearly total responsibility for psychiatric care in given catchment areas. This provides excellent opportunities to describe the frequencies and patterns of the broad spectrum of bipolar illness, including co-morbid substance use disorders, to follow the patients for several years and to do molecular genetic mapping.
Methods: Participating centers consist of outpatient clinics and hospital departments from different parts of Norway and one third-line clinic with referrals from all over Norway. Specifically trained clinicians in each center include bipolar patients systematically and perform the patient evaluation as part of their clinical duties. In addition, CT or MRI scans and EEG are performed and blood samples are collected for clinical chemistry screening and for DNA sampling.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15 years
Clinical Interview. Difference (MADRES) in remission between the study and control group.
Time frame: 15 years
Clinical Interview. Difference (MADRS) in response between the study and control group.
Time frame: 15 years
Clinical Interview. Global Assessment of Function
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Clinical Interview.
Time frame: 1 year
Laboratory
Time frame: 1 year
Laboratory
Time frame: 1 st week
Laboratory, Urine
Time frame: 1 st year
Clinical interview
Time frame: Week 26
Clinical interview
Time frame: Week 1 and week 26
Clinical interview
Contact information is provided by the study sponsor or research team.
Arne Vaaler, PhD MD
CONTACT
Gunnar Morken, PhD MD
CONTACT
Norwegian University of Science and Technology
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00024635
Anxiety Disorders, Behavior
Bethesda, Maryland, United States
View Trial DetailsNCT07411222
Behavior, Bipolar Disorder
Bolu, Turkey (Türkiye)
View Trial DetailsNCT07534475
Bipolar Disorder, Bipolar and Related Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07286175
Bipolar Disorder, Bipolar and Related Disorders
Orange, California, United States
View Trial Details